We are an R&D-driven
specialty drug developer

Executive Leadership Team

"Nexus" signifies connection. Connecting Molecules to Medicine® reflects our dedication to quality—from the source to the finished product. It all starts at the top.

Usman Ahmed

President & CEO

Daniel Wang

Vice President, Finance and Business Development

Stephen Kim

Chief Financial Officer

Omair Ahmed

Chief Operating Officer

Ayesha Ahmed

General Counsel and Vice President, Human Resources

Alex Kruszewski

Executive Vice President, Operations

Sridhar Desikan

Chief Scientific Officer

Vince LoPiccolo

Vice President, Sales

Heidi Brasile

Vice President, Corporate Quality

Daniel Wang

Vice President of Finance and Business Development

Usman Ahmed

President & CEO

Omair Ahmed

Chief Operating Officer

Ayesha Ahmed

General Counsel and Vice President, Human Resources

Alex Kruszewski

Executive Vice President, Operations

Sridhar Desikan

Chief Scientific Officer

Vince LoPiccolo

Vice President, Sales

Heidi Brasile

Vice President, Corporate Quality

Stephen Kim

Chief Financial Officer

Omair Ahmed

Chief Operating Officer

Usman Ahmed

President & CEO

Ayesha Ahmed

General Counsel and Vice President, Human Resources

Alex Kruszewski

Executive Vice President, Operations

Sridhar Desikan

Chief Scientific Officer

Vince LoPiccolo

Vice President, Sales

Heidi Brasile

Vice President, Corporate Quality

Stephen Kim

Chief Financial Officer

Daniel Wang

Vice President, Finance and Business Development

What We Do

At Nexus Pharmaceuticals, we innovate to simplify complex injectable drug manufacturing, making treatments easier to use, less labor-intensive, and more efficient. Our high-quality drugs address critical medical needs, delivering reliable, life-saving care when and where it matters most.

What We've Done

Founded in 2003 by chemists Mariam S. Darsot and Shahid Ahmed, Nexus Pharmaceuticals has been a pioneer in the pharmaceutical industry. We are a fast-growing company with a robust pipeline that has featured several first-to-market specialty and generic drugs.

Where We're Going

We have many critical-need injectable medications in the pipeline, many of which have a history of shortages. Our ability to identify those shortages and meet market needs makes our efforts all the more critical to the medical community.

Our mission drives everything that we do

React transport logo image only